Literature DB >> 28963802

Therapeutic lateral neck dissection in well-differentiated thyroid cancer: Analysis on factors predicting distribution of positive nodes and prognosis.

Davide Lombardi1, Alberto Paderno1, Davide Giordano2, Diego Barbieri3, Stefano Taboni1, Cesare Piazza1, Carlo Cappelli4, Francesco Bertagna5, Verter Barbieri2, Simonetta Piana6, Salvatore Bellafiore6, Giuseppe Spriano7, Giuseppe Mercante7, Piero Nicolai1.   

Abstract

BACKGROUND: Neck dissection is considered the treatment of choice in patients with lateral neck metastases from well-differentiated thyroid cancer.
METHODS: A multicenter, retrospective review of patients who underwent therapeutic lateral neck dissection for well-differentiated thyroid carcinoma was carried out.
RESULTS: The study included a total of 405 lateral neck dissections performed in 352 patients; 197 women (56%) and 155 men (44%). When considering ipsilateral neck metastases, levels IIa, IIb, III, IV, Va, Vb, and V (not otherwise specified) were involved in 42%, 6%, 73%, 67%, 11%, 31%, and 35% of cases, respectively. Five-year and 10-year overall survival (OS) were 93% and 81%, respectively. Age >55 years, pathologic T (pT)4 category, tumor diameter >4 cm, aggressive variants of well-differentiated thyroid carcinoma, endovascular invasion, and number of positive nodes >5 turned out to be the most important prognostic factors.
CONCLUSION: Neck dissection is a valid treatment option in the presence of neck metastasis from well-differentiated thyroid carcinoma. Levels IIa, III, IV, and Vb should always be removed.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  lateral neck metastases; neck dissection; neck levels; survival; well-differentiated thyroid cancer

Mesh:

Year:  2017        PMID: 28963802     DOI: 10.1002/hed.24936

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  3 in total

1.  High rate of IIA/IIB neck groups involvement supports complete lateral neck dissection in thyroid carcinoma.

Authors:  Emilien Chebib; Caroline Eymerit; Nathalie Chabbert-Buffet; Bruno Angelard; Jean Lacau St Guily; Sophie Périé
Journal:  Gland Surg       Date:  2020-12

Review 2.  Thyroid Carcinoma: Phenotypic Features, Underlying Biology and Potential Relevance for Targeting Therapy.

Authors:  Jinwei Hu; Isabella J Yuan; Saied Mirshahidi; Alfred Simental; Steve C Lee; Xiangpeng Yuan
Journal:  Int J Mol Sci       Date:  2021-02-16       Impact factor: 5.923

3.  The Value of Intraoperative Ultrasound in Selective Lateral Cervical Neck Lymphadenectomy for Papillary Thyroid Cancer: A Prospective Pilot Study.

Authors:  Giovanna Di Meo; Francesco Paolo Prete; Giuseppe Massimiliano De Luca; Alessandro Pasculli; Lucia Ilaria Sgaramella; Francesco Minerva; Francesco Antonio Logoluso; Giovanna Calculli; Angela Gurrado; Mario Testini
Journal:  Cancers (Basel)       Date:  2021-05-31       Impact factor: 6.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.